Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Mid-range Performer
1427.9000 3.10 (0.22%)
NSE Dec 22, 2025 15:31 PM
Volume: 80,833
 

1427.90
0.22%
Sharekhan
Quarterly revenues reached Rs. 2,355 crore, marking a 16% y-o-y increase and a 13% rise from the
previous quarter. Profit after tax (PAT) came in strong at Rs. 245 crore, up 39% as compared to last year and 23%, sequentially.
Ipca Laboratories Ltd. has an average target of 1595.00 from 3 brokers.
More from Ipca Laboratories Ltd.
Recommended